Adjuvant Chemotherapy With Gemcitabine and Cisplatin Compared to Standard of Care After Curative Intent Resection of Biliary Tract Cancer
Clinical trial NCT02170090 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02170090
- Sponsor
- Universitätsklinikum Hamburg-Eppendorf
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-04-01
- Primary completion
- 2025-12-01
- Enrollment
- 789
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.